Nainesh Parikh

Robert Suh, M.D. is a Clinical Professor in the Department of Radiological Sciences at the Ronald Reagan UCLA Medical Center and the David Geffen School of Medicine at UCLA. Currently, Dr. Suh serves as the Director of Thoracic Interventional Services and as the Vice Chair of Radiology Education at UCLA Medical Center. Dr. Suh is the current and has been Program Director of the Diagnostic Radiology Residency since 2002.

Dr. Suh's research interests primarily center on thermal ablation, high-dose rate brachytherapy, tissue retrieval, image-guided intratumoral drug delivery and gene profiling technologies in the treatment of pulmonary malignancies, focusing on lung cancer.

Scott Genshaft is an Associate Clinical Professor of Interventional Radiology at UCLA, specializing in minimally invasive, image-guided therapies for thoracic malignancies, painful bone metastases, and knee osteoarthritis. He leads outpatient interventional radiology services across UCLA’s expanding network, with a focus on increasing access to advanced oncologic and palliative procedures in community settings. His work includes leadership in thoracic interventional oncology, musculoskeletal oncology, and participation in trials on thermal ablation and genicular artery embolization.

Outside of work, Scott enjoys traveling with his wife and kids.

Robert Suh, M.D. is a Clinical Professor in the Department of Radiological Sciences at the Ronald Reagan UCLA Medical Center and the David Geffen School of Medicine at UCLA. Currently, Dr. Suh serves as the Director of Thoracic Interventional Services and as the Vice Chair of Radiology Education at UCLA Medical Center. Dr. Suh is the current and has been Program Director of the Diagnostic Radiology Residency since 2002.

Dr. Suh's research interests primarily center on thermal ablation, high-dose rate brachytherapy, tissue retrieval, image-guided intratumoral drug delivery and gene profiling technologies in the treatment of pulmonary malignancies, focusing on lung cancer.

Dr. McClure is a board-certified interventional radiologist and urologist whose expertise is focused on image-guided therapy and minimally invasive treatment of urologic disease. Dr. McClure is Director of Focal Therapy and Interventional Urology at Weill Cornell Medicine. His research interests include improved diagnosis and imaging for prostate cancer, focal therapy for prostate cancer, renal mass biopsy and ablation, and prostate artery embolization.

Chief of Interventional Radiology, Mass General Brigham; Associate Professor, Harvard Medical School.
Introduced cryoablation ablations at MGH. Involved in liver, kidney and soft tissue ablations for pain control. Has published articles in renal interventions including renal and adrenal ablations. Organized ablation workshops nationally and internatinally which included lectures, panel discussions, and live demonstration workshops for liver tumor ablation. Invited speaker and moderator for multiple conferences including SIR, ARRS, SIO and CIO. Has also led projects and preseented talks related to Machine Learning and application of mixed reality in Interventional Radiology.

Adeel Kaiser, M.D., is a board-certified radiation oncologist at Miami Cancer Institute and Director of the Radiopharmaceutical Therapy Program. He has expertise in the treatment of a number of solid tumor malignancies, with a special focus on genitourinary and gastrointestinal cancers. He also has significant experience in proton therapy dating back to 2008, when he served as an assistant professor at Loma Linda University Medical Center, the first clinical proton therapy center in the United States. Dr. Kaiser joined Miami Cancer Institute in 2020 from the University of Maryland Department of Radiation Oncology, where he served as Fellowship Director as well as Director of the Integrative Wellness Program.

Dr. Narayanan is an Interventional Radiologist at the Miami Cardiac and Vascular Institute and the Chief of Interventional Oncology at the Miami Cancer Institute. Dr. Narayanan is board-certified in diagnostic radiology and holds a Certificate of Added Qualification in interventional radiology.

Most recently, he served as medical director of Interventional Radiology at University of Miami Hospital and Clinics, and as the founding chairman of the Department of Interventional Radiology at the University Of Miami Miller School Of Medicine, where he also served as a Professor of interventional Radiology.

Dr. Narayanan’s primary clinical research interests include pancreatic, liver and colon cancer. He is widely published in such high-impact medical journals as Cancer, Journal if Vascular and Interventional Radiology and Cardiovascular and Interventional Radiology and serves as a reviewer and editor for several scientific publications. He has authored text book chapters and is an invited faculty member and speaker at national and international scientific meetings.

Yolanda Bryce, MD, RPVI completed her Medical School training at Loma Linda University School of Medicine in 2009, followed by a Diagnostic Radiology Residency at Mount Auburn Hospital in Cambridge, Massachusetts in 2014, a subspecialty training in Breast Imaging at Memorial Sloan Kettering Cancer Center (MSKCC) in 2015, and a Fellowship in Vascular and Interventional Radiology at Miami Cardiac and Vascular Institute in 2016. She joined the faculty at Memorial Sloan Kettering Cancer Center in August 2016 where she pioneers minimally invasive cryoablation technique to treat locoregional disease in patients that are poor surgical candidates or refuse surgery and works in a multidisciplinary team to expand treatment options for patients with metastatic breast cancer through interventional oncology. She also specializes in vascular disease in oncologic patients, boarded through the American Board of Vascular Medicine and holding a Registered Physician Vascular Interpretation (RPVI) certification. In 2018, she became the founding director of MSKCC’s Noninvasive Vascular Imaging Center and started the institution’s PAD program improving mobility and quality of life of some of the most vulnerable patients – those with both cancer and life-limiting PAD. Her PAD screening trial examines the prevalence and disparities of PAD in at-risk cancer patients.

Alan Sag, MD, FSIR is a Vascular and Interventional Radiologist at the University of Miami with special expertise in embolization and ablation, as well as musculoskeletal, pain, and thyroid interventions

Constantino S. Peña, M.D., serves as the Section Head of interventional radiology. He is the medical director of vascular imaging at Baptist Health Miami Cardiac & Vascular Institute.
Dr. Peña earned his bachelor’s and master’s degrees from Stanford University, and his medical degree from Yale University School of Medicine. He completed his residency in diagnostic radiology and a vascular and interventional fellowship in Massachusetts General Hospital in Boston, Massachusetts.
Dr. Peña is a clinical associate professor of radiology at Florida International University Herbert Wertheim College of Medicine. He has presented in numerous national and international meetings as well as participated in multiple clinical trials.
He has served for many professional organizations. He serves as the chair for the Cardiovascular Radiology & Intervention Council of the American Heart Association. He presently serves on the executive council of the Society of Interventional Radiology and was a past Annual Meeting Chair. He has served on several committee on the American Board of radiology and is a Board examiner. He also served on the Radiology Info Committee of the American College of Radiology and Radiological Society of North America and the Society of Interventional Radiology Oncology Service Line.
Dr. Peña is a fellow of the Society of Interventional Radiology, American Heart Association and the Society of Cardiovascular Computed Tomography (CT). He is also a member of the Radiological Society of North America, American College of Radiology, Society of Cardiovascular CT, Iberoamerican Society of Interventional Radiology and the North American Society for Cardiac Imaging.

Dr. Parikh’s area of focus is benign prostatic hyperplasia (BPH), prostate cancer and kidney cancer as well as primary and secondary liver cancer. As a widely recognized expert on the utilization of prostate artery embolization (PAE) for the management of patients with prostate cancer, Dr. Parikh is dedicated to advancing innovative oncologic care and founded the PAE program at Moffitt Cancer Center in 2017. He has also published several manuscripts on the topic and currently serves as the primary investigator for a clinical trial studying the role of neoadjuvant PAE prior to definitive radiotherapy for men with prostate cancer (https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-2083…). Dr. Parikh has also served in several leadership roles for Moffitt Cancer Center and is currently the Vice President, Chief Clinical Expansion and Partnership Officer. In this role he focuses on clinical growth initiatives and partnerships that bring MoffittCare to the community, closer to patients' homes. He previously served as Assistant Chief Medical Officer with a focus on finance, strategy and digital innovation. Dr. Parikh earned his undergraduate degree from Columbia University in NYC and subsequently worked as an investment banker on Wall Street. Determined to make a significant impact on the daily lives of patients, he obtained MD and MBA degrees from Tufts University School of Medicine in Boston, MA. He then completed diagnostic radiology residency at NYU Medical Center in New York City, before moving back to Boston to complete a fellowship in Angiography and Interventional Radiology at the Brigham and Women’s Hospital – Harvard Medical School.